companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

Pephexia Therapeutics ApS

CVR: 41319208

Micro companyEstablished (6 yrs)Loss-making
Active
Own this company?

About Pephexia Therapeutics ApS

Pephexia Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Keld Fogtmann Fosgerau. The company is owned by Fogtmann Fosgerau Holding ApS and Andrew Justin Stewart Coats. In 2025, the company reported a gross profit of DKK -179,735 and a net result of DKK -4,440,533 compared with DKK -5,320,870 the year before. Equity amounted to DKK -19,747,345.

Your company? Claim the profile and show your logo, website and social channels — for free.

Claim this profile

Overview

Company type
APS
Anpartsselskab
Address
c/o Keld Fosgerau, Nordre Fasanvej 215 4., 2000 Frederiksberg
FREDERIKSBERG
2000 Frederiksberg
Find nearby companies
Founded
24.4.2020

Details

Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Code: 721000
Capital
71.654 kr.

Contact

Advertising protected
Phone
Log in to see
Email
Log in to see
Website
www.pephexia.com

Purpose

Virksomhedens formål er forskning og udvikling af lægemidler samt anden dermed beslægtet virksomhed efter direktionens skøn.

Location

Google Maps|Apple Maps|OpenStreetMap

Financials

YearRevenueProfit/LossTotal AssetsEquityEmployeesReport
2025--4.4 mio.2 mio.-19.7 mio.4
2024--5.3 mio.5.9 mio.-15.3 mio.4
2023--5.4 mio.5.3 mio.-12.6 mio.3
2022--6.7 mio.9.7 mio.-7.1 mio.3
2021626 t.-4.5 mio.4.8 mio.-2.7 mio.0

Find more companies like Pephexia Therapeutics ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Industry Benchmarks

View industry report

Compared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

Employees
Company4
Industry median4
About average
Equity ratio
Company-979.4%
Industry median72.0%
100% below

Comparison is based on industry median values

Ownership

Owners
Fogtmann Fosgerau Holding ApS
CVR: 41241470
50-66,65%
Andrew Justin Stewart Coats
5-9,99%
Pephexia Therapeutics ApS
CVR: 41319208

Management

Directors

Keld Fogtmann Fosgerau(DIREKTØR)

Board

Anders Mørkeberg Hinsby(FORMAND)
Andrew Justin Stewart Coats(BESTYRELSESMEDLEM)
Keld Fogtmann Fosgerau(BESTYRELSESMEDLEM)
Mats Peter Blom(BESTYRELSESMEDLEM)
Ricki Boye(BESTYRELSESMEDLEM)
Stefan Dietmar Anker(BESTYRELSESMEDLEM)

PEP screening

Screen owners and management against the Danish FSA's official PEP lists

Founders

Fogtmann Fosgerau Holding ApS

Production units (1)

Pephexia Therapeutics ApS
P-no: 1025771482
Nordre Fasanvej 215 4., 2000, Frederiksberg
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

Is this your company?

Free

Claim this page to add your logo and social links. Free to get started.

  • Verified badge on your profile
  • Upload your logo
  • Links to your website and social channels

History

25 events
2026
Pephexia Therapeutics ApS: The 2025 annual report is outJun 1, 2026

Pephexia Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -179,735, and the net result was DKK -4,440,533.

Pephexia Therapeutics ApS updates contact informationMay 28, 2026

Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (May 28, 2026).

Ricki Boye joins the board of Pephexia Therapeutics ApSMay 27, 2026

As of May 27, 2026, Ricki Boye has joined the board of directors of Pephexia Therapeutics ApS.

Pephexia Therapeutics ApS updates contact informationMay 15, 2026

Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (May 15, 2026).

Pephexia Therapeutics ApS updates contact informationApr 1, 2026

Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (April 1, 2026).

Pephexia Therapeutics ApS updates contact informationMar 31, 2026

Contact info changed: new phone: 50910969, new email: [email protected], new website: www.pephexia.com (March 31, 2026).

2025
Pephexia Therapeutics ApS: The 2024 annual report is outApr 22, 2025

Pephexia Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -2,085,438, and the net result was DKK -5,320,870.

2024
Pephexia Therapeutics ApS: The 2023 annual report is outMay 24, 2024

Pephexia Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -3,212,128, and the net result was DKK -5,439,731.

Stefan Dietmar Anker joins the board of Pephexia Therapeutics ApSMay 22, 2024

As of May 22, 2024, Stefan Dietmar Anker has joined the board of directors of Pephexia Therapeutics ApS.

Yann Albert André Colardelle leaves the board of Pephexia Therapeutics ApSMay 22, 2024

As of May 22, 2024, Yann Albert André Colardelle has left the board of directors of Pephexia Therapeutics ApS.

2023
Pephexia Therapeutics ApS: The 2022 annual report is outMay 22, 2023

Pephexia Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -5,266,259, and the net result was DKK -6,677,466.

2022
Pephexia Therapeutics ApS appoints new auditorDec 16, 2022

As of December 16, 2022, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Pephexia Therapeutics ApS.

Fogtmann Fosgerau Holding ApS registered as owner of Pephexia Therapeutics ApSNov 22, 2022

As of November 22, 2022, Fogtmann Fosgerau Holding ApS is registered as an owner of Pephexia Therapeutics ApS with an ownership share of 50%.

Keld Fogtmann Fosgerau joins the board of Pephexia Therapeutics ApSJul 7, 2022

As of July 7, 2022, Keld Fogtmann Fosgerau has joined the board of directors of Pephexia Therapeutics ApS.

Anders Mørkeberg Hinsby joins the board of Pephexia Therapeutics ApSJul 7, 2022

As of July 7, 2022, Anders Mørkeberg Hinsby has joined the board of directors of Pephexia Therapeutics ApS.

Keld Fogtmann Fosgerau leaves the board of Pephexia Therapeutics ApSJul 6, 2022

As of July 6, 2022, Keld Fogtmann Fosgerau has left the board of directors of Pephexia Therapeutics ApS.

Pephexia Therapeutics ApS: The 2021 annual report is outMay 17, 2022

Pephexia Therapeutics ApS has published its annual report for 2021. Revenue came to DKK 626,000, and the net result was DKK -4,532,328.

2021
Pephexia Therapeutics ApS publishes interim reportApr 26, 2021

Pephexia Therapeutics ApS has published its interim report for the period April 24, 2020 – December 31, 2020.

2020
Keld Fogtmann Fosgerau joins the board of Pephexia Therapeutics ApSNov 2, 2020

As of November 2, 2020, Keld Fogtmann Fosgerau has joined the board of directors of Pephexia Therapeutics ApS.

Yann Albert André Colardelle joins the board of Pephexia Therapeutics ApSNov 2, 2020

As of November 2, 2020, Yann Albert André Colardelle has joined the board of directors of Pephexia Therapeutics ApS.

Mats Peter Blom joins the board of Pephexia Therapeutics ApSNov 2, 2020

As of November 2, 2020, Mats Peter Blom has joined the board of directors of Pephexia Therapeutics ApS.

Andrew Justin Stewart Coats joins the board of Pephexia Therapeutics ApSNov 2, 2020

As of November 2, 2020, Andrew Justin Stewart Coats has joined the board of directors of Pephexia Therapeutics ApS.

Registered as owner of Pephexia Therapeutics ApSNov 2, 2020

As of November 2, 2020, is registered as an owner of Pephexia Therapeutics ApS with an ownership share of 5%.

Keld Fogtmann Fosgerau joins Pephexia Therapeutics ApS as directorApr 24, 2020

As of April 24, 2020, Keld Fogtmann Fosgerau is registered as director of Pephexia Therapeutics ApS.

Pephexia Therapeutics ApS is foundedApr 24, 2020

Pephexia Therapeutics ApS was founded on April 24, 2020.

Similar companies

Companies in the same industry and area

KurbeGroup ApS

CVR 40766383

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik2.1 kmKØBENHAVN

Maleckis Biotech Consulting

CVR 46613139

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik2.4 kmKØBENHAVN

CLIMATELAB ApS

CVR 34688605

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik2.7 kmKØBENHAVN1 employees

RSH Consult

CVR 44504332

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik2.9 kmKØBENHAVN

ELKMO

CVR 43917897

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik3.0 kmKØBENHAVN